Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699511010 | Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699512015 | Chlorothiazide 500 mg and reserpine 125 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing chlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing reserpine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Reserpine - chemical | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Chlorothiazide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing chlorothiazide and reserpine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Centrally acting hypotensive agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Reserpine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Chlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Chlorothiazide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.125 | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Chlorothiazide (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Chlorothiazide (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Chlorothiazide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing chlorothiazide and reserpine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 125 | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Diuretic therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR